Discovery of a Drug-like, Natural Product-Inspired DCAF11 Ligand Chemotype

Nat Commun. 2023 Nov 30;14(1):7908. doi: 10.1038/s41467-023-43657-6.

Abstract

Targeted proteasomal and autophagic protein degradation, often employing bifunctional modalities, is a new paradigm for modulation of protein function. In an attempt to explore protein degradation by means of autophagy we combine arylidene-indolinones reported to bind the autophagy-related LC3B-protein and ligands of the PDEδ lipoprotein chaperone, the BRD2/3/4-bromodomain containing proteins and the BTK- and BLK kinases. Unexpectedly, the resulting bifunctional degraders do not induce protein degradation by means of macroautophagy, but instead direct their targets to the ubiquitin-proteasome system. Target and mechanism identification reveal that the arylidene-indolinones covalently bind DCAF11, a substrate receptor in the CUL4A/B-RBX1-DDB1-DCAF11 E3 ligase. The tempered α, β-unsaturated indolinone electrophiles define a drug-like DCAF11-ligand class that enables exploration of this E3 ligase in chemical biology and medicinal chemistry programs. The arylidene-indolinone scaffold frequently occurs in natural products which raises the question whether E3 ligand classes can be found more widely among natural products and related compounds.

MeSH terms

  • Biological Products* / pharmacology
  • Cullin Proteins* / metabolism
  • Ligands
  • Oxindoles
  • Proteasome Endopeptidase Complex / metabolism
  • Proteolysis
  • Ubiquitin-Protein Ligases / metabolism
  • Ubiquitination

Substances

  • Oxindoles
  • Ligands
  • Cullin Proteins
  • Ubiquitin-Protein Ligases
  • Proteasome Endopeptidase Complex
  • Biological Products